Home Other Building Blocks 362703-57-9
362703-57-9,MFCD07784120
Catalog No.:AA00BYVJ

362703-57-9 | Methyl 2-(1-Boc-piperidin-4-yl)-beta-glycinate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
98%
in stock  
$128.00   $89.00
- +
250mg
98%
in stock  
$261.00   $183.00
- +
1g
95%
in stock  
$589.00   $412.00
- +
5g
98%
in stock  
$2,007.00   $1,405.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00BYVJ
Chemical Name:
Methyl 2-(1-Boc-piperidin-4-yl)-beta-glycinate
CAS Number:
362703-57-9
Molecular Formula:
C13H24N2O4
Molecular Weight:
272.3407
MDL Number:
MFCD07784120
SMILES:
COC(=O)CC1(N)CCN(CC1)C(=O)OC(C)(C)C
Properties
Computed Properties
 
Complexity:
341  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
5  
XLogP3:
0.9  

Downstream Synthesis Route

[1]Gilmore,JohnL.;King,BryanW.;Harris,Cathy;Maduskuie,Thomas;Mercer,StephenE.;Liu,Rui-Qin;Covington,MaryanneB.;Qian,Mingxin;Ribadeneria,MariaD.;Vaddi,Krishna;Trzaskos,JamesM.;Newton,RobertC.;Decicco,CarlP.;Duan,JamesJ.-W.[BioorganicandMedicinalChemistryLetters,2006,vol.16,#10,p.2699-2704]

[1]CurrentPatentAssignee:Duan,Jingwu;King,BryanW.;Decicco,Carl;MaduskuieJR.,ThomasP.;Voss,MathewE.-US2004/72802,2004,A1Locationinpatent:Page/Pagecolumn49

[2]Gilmore,JohnL.;King,BryanW.;Harris,Cathy;Maduskuie,Thomas;Mercer,StephenE.;Liu,Rui-Qin;Covington,MaryanneB.;Qian,Mingxin;Ribadeneria,MariaD.;Vaddi,Krishna;Trzaskos,JamesM.;Newton,RobertC.;Decicco,CarlP.;Duan,JamesJ.-W.[BioorganicandMedicinalChemistryLetters,2006,vol.16,#10,p.2699-2704]

[3]CurrentPatentAssignee:RAZETHERAPEUTICS-WO2017/156177,2017,A1Locationinpatent:Paragraph00352

[1]Gilmore,JohnL.;King,BryanW.;Harris,Cathy;Maduskuie,Thomas;Mercer,StephenE.;Liu,Rui-Qin;Covington,MaryanneB.;Qian,Mingxin;Ribadeneria,MariaD.;Vaddi,Krishna;Trzaskos,JamesM.;Newton,RobertC.;Decicco,CarlP.;Duan,JamesJ.-W.[BioorganicandMedicinalChemistryLetters,2006,vol.16,#10,p.2699-2704]

[1]Gilmore,JohnL.;King,BryanW.;Harris,Cathy;Maduskuie,Thomas;Mercer,StephenE.;Liu,Rui-Qin;Covington,MaryanneB.;Qian,Mingxin;Ribadeneria,MariaD.;Vaddi,Krishna;Trzaskos,JamesM.;Newton,RobertC.;Decicco,CarlP.;Duan,JamesJ.-W.[BioorganicandMedicinalChemistryLetters,2006,vol.16,#10,p.2699-2704]

362703-57-9   
N-{4-2-(hydroxyamino)-2-oxoethyl-1-methyl-4-piperidinyl}-4--(2-methyl-4-quinolinyl)methoxybenzamide 

[1]Gilmore,JohnL.;King,BryanW.;Harris,Cathy;Maduskuie,Thomas;Mercer,StephenE.;Liu,Rui-Qin;Covington,MaryanneB.;Qian,Mingxin;Ribadeneria,MariaD.;Vaddi,Krishna;Trzaskos,JamesM.;Newton,RobertC.;Decicco,CarlP.;Duan,JamesJ.-W.[BioorganicandMedicinalChemistryLetters,2006,vol.16,#10,p.2699-2704]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:362703-57-9 Molecular Formula|362703-57-9 MDL|362703-57-9 SMILES|362703-57-9 Methyl 2-(1-Boc-piperidin-4-yl)-beta-glycinate